Zachary Bowens

Mr. Zachary Bowens

greenwood Genetics Center
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ASAlison M. Sansone
Alison M. Sansone
BHBrooke Hisrich
Brooke Hisrich
RYR. Brandt Young
R. Brandt Young
WAWilliam F. Abel
William F. Abel
ZBZachary Bowens
Zachary Bowens
Anna BlendaAnna Blenda
Anna Blenda
(1) Background: Endometriosis is characterized by the presence of endometrial glands and stroma outside of the uterus and is often associated with severe pelvic pain and infertility. Our study explored the utilization of B-Cell Lymphoma 6 (BCL6) and Sirtuin 1 (SIRT1) as potential biomarkers in serum, plasma, urine, and cervical mucus for a non-invasive diagnostic test for endometriosis. BCL6 was chosen based on its previously reported elevated expression in endometrial biopsies, and SIRT1 is co-expressed and upregulated in the endometrium of women with endometriosis. (2) Methods: BCL6 and SIRT1 levels were measured using enzyme-linked immunoassay (ELISA) in samples from 20 women with endometriosis (ten with stages I/II and ten with stages III/IV) and ten women without endometriosis. (3) Results: Levels of SIRT1 in sera showed a statistically significant elevation in advanced stages III/IV compared to controls and stages I/II. No significant differences were found in other bodily fluids for SIRT1 or any bodily fluids tested for BCL6. (4) Conclusions: These results suggest some potential of SIRT1 expression within serum as a predictor of advanced asymptomatic stages of endometriosis. Using immunohistochemistry (IHC) staining and H-SCORE values for the elevated BCL6 (and potentially SIRT1) levels in endometrial biopsy samples seems to have higher diagnostic potential based on the previously published studies.

4 February 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
BHBrooke Hisrich
Brooke Hisrich
RYR. Brant Young
R. Brant Young
ASAlison M. Sansone
Alison M. Sansone
ZBZachary Bowens
Zachary Bowens
LGLisa J. Green
Lisa J. Green
Anna BlendaAnna Blenda
Anna Blenda
Galectins are a family of β-galactoside-binding proteins that contribute to multiple cellular functions, including immune surveillance and apoptosis. Human galectins are also important regulators of inflammation, making them a research target for various inflammatory diseases and tumorigenesis associated with pro-inflammatory conditions. This review focuses on the involvement of human galectins in modulation of inflammation and in the pathophysiology of endometriosis and endometriosis-associated neoplasms. Endometriosis is a chronic inflammatory disease with unknown etiology. Galectins-1, -3 and -9 were found to be overexpressed in ectopic and eutopic endometrium of females with endometriosis compared to those without endometriosis. These findings suggest galectins’ role in the progression on endometriotic lesions and their potential use as diagnostic biomarkers and/or targets for therapeutic approaches. Galectins-1, -3, and -9 have also been implicated in the development of endometriosis-associated neoplasms. Furthermore, galectin-3 has been shown to interact with KRAS protein and contribute to cellular growth, proliferation, inflammation, and the uptake of nutrients in endometriotic lesions and may be involved in the maintenance and propagation of endometriosis. These galectins have been shown to be upregulated in certain forms of cervical, ovarian, endometrial, and colon cancer associated with endometriosis and have become a potential target for anti-cancer therapies.

23 September 2025 in Cureus
Verified
Journal Article
Open access
PDF file
ZBZachary Bowens
Zachary Bowens
HFHannah Flynn
Hannah Flynn
JWJordan Winebrenner
Jordan Winebrenner
MCMichaeleena Carr
Michaeleena Carr
LTLindsay Tjiattas-Saleski
Lindsay Tjiattas-Saleski
Necrotizing fasciitis (NF) presents a formidable clinical challenge due to its rapid progression and potentially fatal outcomes. This case report describes the presentation, management, and outcomes of a 33-year-old female with advanced perineal NF. The report underscores the importance of prompt recognition, surgical debridement, and targeted antimicrobial therapy in optimizing patient outcomes. An extensive literature review was conducted to provide additional context, focusing on the epidemiology, pathophysiology, diagnostic modalities, and treatment strategies for NF. Notably, this case highlights a novel synergistic relationship between beta-hemolytic Streptococcus and Streptococcus anginosus, contributing to the evolving understanding of NF pathogenesis. Collaborative interdisciplinary care remains paramount for improving survival in this complex and life-threatening condition.